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Osteoarthritis (OA) is the most common rheumatic pathology. It is related with 
aging, and it is characterized mainly by cartilage degradation. Therefore, new diagnostic 
tests for OA are urgently needed, which also allow the efficient development of 
alternative therapeutic strategies. Considering that OA process implies different tissues 
and complex biological processes, the most promising diagnostic strategy seems to be 
the study of a combination of different biomarkers. Recently, using iTRAQ 
methodology (ABSCIEX), by two dimensional LC coupled to MALDI-TOF/TOF mass 
spectrometry and ProteinPilot 2.0 software (ABSCIEX, we have identified 349 proteins 
in serum and 113 proteins in synovial fluid of patients with Knee OA. This panel of 
proteins let us to find a pool of biomarkers with differential expression in OA patients 
and in healthy people with relevance to diagnostic and prognostic of OA. Significant 
advances have occurred in the symptomatic management of OA over the past several 
decades. The development of so called disease-modifying osteoarthritis drugs 
(DMOADs) is still in a formative stage. In this sense, to find new therapeutic targets to 
OA, we have carried out a pharmacoproteomic approach using DIGE and SILAC 
methodology in human articular chondrocytes treated with both Glucosamine Sulfate 
and Chondroitin Sulfate. Results showed that 31 different proteins were altered by GS 
or/and CS treatment when compared to control, 35% of the proteins modulated by GS 
are involved in signal transduction pathways, 15% in redox and stress response, and 
25% in protein synthesis and folding processes. 
 
